ENHANCING CANCER THERAPY: THE IMPACT OF PARP INHIBITORS - Hardha, B;Gowramma, B
44,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
22 °P sammeln
  • Broschiertes Buch

The Book explores the role of PARP inhibitors in advancing cancer therapy, focusing on their effectiveness in targeting cancer cells with specific genetic vulnerabilities. It examines how these drugs improve treatment outcomes for various cancers, particularly those with BRCA mutations. Additionally, also addresses the challenge of resistance mechanisms that can diminish the efficacy of PARP inhibitors over time. Strategies to overcome these resistance mechanisms and enhance the sustained effectiveness of PARP inhibitors in cancer treatment are also discussed.

Andere Kunden interessierten sich auch für
Produktbeschreibung
The Book explores the role of PARP inhibitors in advancing cancer therapy, focusing on their effectiveness in targeting cancer cells with specific genetic vulnerabilities. It examines how these drugs improve treatment outcomes for various cancers, particularly those with BRCA mutations. Additionally, also addresses the challenge of resistance mechanisms that can diminish the efficacy of PARP inhibitors over time. Strategies to overcome these resistance mechanisms and enhance the sustained effectiveness of PARP inhibitors in cancer treatment are also discussed.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Mrs. B. Hardha is a research scholar at JSS College of Pharmacy in Ooty. She has accumulated 2.5 years of experience in both academics and research. Dr. B.Gowramma is an Associate Professor at JSS College of Pharmacy in Ooty, with over 23 years of experience in academics and research with more than 115 paper publications.